Entity

Time filter

Source Type

Salt Lake City, UT, United States

Juneau Biosciences is a biotechnology company based in Salt Lake City, Utah. The firm applies both population genetics and genomics approaches to identify the fundamental, molecular bases of major diseases that predominantly affect women. Founded in early 2007 by Dr. Kenneth Ward, the firm has focused so far on the development of molecular diagnostics and therapeutics for endometriosis. Wikipedia.


Patent
Juneau Biosciences | Date: 2012-09-04

The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.


Patent
Juneau Biosciences | Date: 2013-03-07

The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.


Patent
Juneau Biosciences | Date: 2011-06-13

The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.


Patent
Juneau Biosciences | Date: 2010-04-22

The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.


Discover hidden collaborations